This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignees: Nuvelo, Inc., Hyseq, Inc.. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2005
Title: Brian Paul Chadwick: Innovator in CD39-like Polypeptides
Introduction
Brian Paul Chadwick is a notable inventor based in Allston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods and compositions relating to CD39-like polypeptides and nucleic acids. With a total of nine patents to his name, Chadwick's work has implications for therapeutic, diagnostic, and research applications.
Latest Patents
Chadwick's latest patents focus on novel polynucleotides and proteins encoded by such polynucleotides. These inventions provide therapeutic, diagnostic, and research utilities for the polynucleotides and proteins. Specifically, the polypeptides and polynucleotides of his inventions comprise amino acid and nucleic acid sequences of a novel CD39-like gene and its gene products.
Career Highlights
Throughout his career, Chadwick has worked with various companies, including Nuvelo, Inc. and Hyseq, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Chadwick has collaborated with notable professionals, including Anna-Maria Frischauf, enhancing the scope and impact of his research and inventions.
Conclusion
Brian Paul Chadwick's innovative work in the field of CD39-like polypeptides and nucleic acids showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing therapeutic and diagnostic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile